ScholarLens Back to search
2010•Xiandai yufang yixueRequires access

CLINICAL OBSERVATION OF MOXIFLOXACIN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION

Huang Xue-yin

Open publisher page 0 citations

Abstract

[Objective] To evaluate the effect of Moxifloxacin injection in treatment of chronic obstructive pulmonary disease exacerbation.[Methods] Control group were injected by levofloxacin.Experimental group received moxifloxacin 0.4g per day intravenously.The treatment course of the two groups was 5-7 days.[Results] The effective rates of moxifloxacin and levofloxacin were 96% and 80%,respectively,and bacterial clearance rates were 93.7% and 64.8%,respectively.The treatment effect of treatment group was effective than the control group.[Conclusion] Injection of moxifloxacin AECOPD was safe and satisfaction,which has high clinical value.

About this research paper

What this paper is about

[Objective] To evaluate the effect of Moxifloxacin injection in treatment of chronic obstructive pulmonary disease exacerbation.[Methods] Control group were injected by levofloxacin.Experimental group received moxifloxacin 0.4g per day intravenously.The treatment course of the two groups was 5-7 days.[Results] The effective rates of moxifloxacin and levofloxacin were 96% and 80%,respectively,and bacterial clearance rates were 93.7% and 64.8%,respectively.The treatment effect of treatment group was effective than the control group.[Conclusion] Injection of moxifloxacin AECOPD was safe and satisfaction,which has high clinical value.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To evaluate the effect of Moxifloxacin injection in treatment of chronic obstructive pulmonary disease exacerbation.[Methods] Control group were injected by levofloxacin.Experimental group received moxifloxacin 0.4g per day intravenously.The treatment course of the two groups was 5-7 days.[Results] The effective rates of moxifloxacin and levofloxacin were 96% and 80%,respectively,and bacterial clearance rates were 93.7% and 64.8%,respectively.The treatment effect of treatment group was effective than the control group.[Conclusion] Injection of moxifloxacin AECOPD was safe and satisfaction,which has high clinical value.

Key concepts: Moxifloxacin, Levofloxacin, Medicine, Exacerbation, Pulmonary disease, Ofloxacin, COPD, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CLINICAL OBSERVATION OF MOXIFLOXACIN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION — Research Paper | ScholarLens